Immucell
$6.35
7
+$0.02+0.32% Today
Statistics
Day High
6.49
Day Low
6.33
52W High
7.6
52W Low
4.52
Volume
9,246
Avg. Volume
17,708
Mkt Cap
57.44M
P/E Ratio
29.57
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-8.14%Profit Margin
Unprofitable52.99MRevenue
-4.31MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ICCC. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap63.86B
Elanco Animal Health
ELAN
Mkt Cap11B
Idexx Laboratories
IDXX
Mkt Cap50.36B
Phibro Animal Health
PAHC
Mkt Cap1.76B
Merck
MRK
Mkt Cap214.76B
Pfizer
PFE
Mkt Cap140.15B
Abbott Laboratories
ABT
Mkt Cap214.96B
Novartis
NVS
Mkt Cap237.61B
About
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Show more...
CEO
Mr. Michael F. Brigham
Employees
69
Country
US
ISIN
US4525253062
Listings
0 Comments
Share your thoughts
FAQ
What is Immucell stock price today?▼
The current price of ICCC is $6.35 USD — it has increased by +0.32% in the past 24 hours. Watch Immucell stock price performance more closely on the chart.
What is Immucell stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Immucell stocks are traded under the ticker ICCC.
Is Immucell stock price growing?▼
ICCC stock has fallen by -1.4% compared to the previous week, the month change is a -3.35% fall, over the last year Immucell has showed a +27% increase.
What is Immucell market cap?▼
Today Immucell has the market capitalization of 57.44M
When is the next Immucell earnings date?▼
Immucell is going to release the next earnings report on May 20, 2026.
What were Immucell earnings last quarter?▼
ICCC earnings for the last quarter are -0.31 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Immucell revenue for the last year?▼
Immucell revenue for the last year amounts to 52.99M USD.
What is Immucell net income for the last year?▼
ICCC net income for the last year is -4.31M USD.
How many employees does Immucell have?▼
As of April 01, 2026, the company has 69 employees.
In which sector is Immucell located?▼
Immucell operates in the Health Care sector.
When did Immucell complete a stock split?▼
Immucell has not had any recent stock splits.
Where is Immucell headquartered?▼
Immucell is headquartered in Portland, US.